/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Options
Charts
News
Company
Financials
Insiders
Filings
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for OSI Pharmaceuticals Inc. (OSIP) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 34.18\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 0.01\n\n (+0.03%)\n\n \n\n \n\n \n\n \n\n Volume: 472.8 k\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n
\n \n \n \n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n\n
\n After Hours: \n $ 34.16 \n \n \n \n \n   \n -0.02\n (-0.06%)\n \n \n \n Volume: 611\n \n \n \n4:22 PM EST Feb 9, 2010\n\n \n
\n
\n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
February 13,2009
\n \n
Close: \n 42.44\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
July 02,2009
\n \n
Close: \n 27.01\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
34.18
\n 		\n\n \n \n \n
Change $
\n \n 0.01\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 0.03%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
33.56
\n 		\n \n \n \n\n
Bid Size
300
\n 		\n \n \n \n
Ask
36.50
\n\n 		\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
34.49
\n 		\n \n \n \n
High
34.70
\n 		\n\n \n \n \n
Low
34.00
\n 		\n \n\n \n \n
Prev Close
34.17
\n
\n \n\n \n \n
Last Trade
4:00
\n 		\n \n \n \n
Volume
472.8 k
\n 		\n \n \n \n
\n
52 Wk Hi
42.44
\n 		\n\n \n \n \n
52 Wk Low
27.01
\n
\n \n\n \n \n
Market Cap
1.98 b
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
58,047,476
\n 		\n \n \n \n
EPS (TTM)
6.33
\n 		\n \n \n \n\n
PE Ratio
5.40
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Global Select (NGS)
\n
\n
\n
\n
\n
\n \n
Exchange
NGS
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for OSI Pharmaceuticals Inc.\n\n \n\n  (OSIP) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for OSIP\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Feb 09, 2010
\n\n \n\n\n\n
10:00 AM\n\n\n\n OSI Pharmaceuticals to Announce Fourth Quarter and Year-End 2009 Financial Results on February 23, 2010 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 28, 2010
\n\n \n\n\n\n
8:00 AM\n\n\n\n Novella Clinical and OSI Pharmaceuticals Expand Clinical Services Agreement - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 15, 2010
\n\n \n\n\n\n
12:41 PM\n\n\n\n FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 14, 2010
\n\n \n\n\n\n
10:29 AM\n\n\n\n Aureon Laboratories Announces Appointment of New Executive Vice President and CFO - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 12, 2010
\n\n \n\n\n\n
9:00 AM\n\n\n\n OSI Pharmaceuticals, Inc. Announces Fourth Quarter and 2009 Full Year Tarceva Sales at JP Morgan Healthcare Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 06, 2010
\n\n \n\n\n\n
11:38 AM\n\n\n\n OSI Pharmaceuticals to Present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12, 2010 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 29, 2009
\n\n \n\n\n\n
10:01 AM\n\n\n\n U.S. Patent and Trademark Office Grants Reissued Patent Replacing OSI Pharmaceuticals' Tarceva(R) Composition of Matter Patent - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 22, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n OSI Pharmaceuticals Updates Preliminary Revenue & Re-affirms Adjusted Earnings Growth Rate Guidance for 2010 - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 16, 2009
\n\n \n\n\n\n
4:50 PM\n\n\n\n OSI Pharmaceuticals Announces Conference Call on ODAC Review of Tarceva(R) for Use as First-line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer - Business Wire
4:40 PM\n\n\n\n FDA Advisory Committee Recommends Against Approving Tarceva for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 08, 2009
\n\n \n\n\n\n
9:33 AM\n\n\n\n Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 24, 2009
\n\n \n\n\n\n
9:01 AM\n\n\n\n NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director - PR Newswire
\n\n More News for OSIP >>
\n\n\n\n \n\n \n\n Filings for OSIP \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Feb 04, 2010
\n\n \n\n\n\n
12:00 AMAn amendment to the SC 13G filing - Form SC 13G/A\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 29, 2010
\n\n \n\n\n\n
12:00 AMA statement of beneficial ownership of common stock by certain persons - Form SC 13G\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 19, 2010
\n\n \n\n\n\n
12:00 AMReport of unscheduled material events or corporate changes - Form 8-K\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 12, 2010
\n\n \n\n\n\n
12:00 AMReport of unscheduled material events or corporate changes - Form 8-K\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jan 11, 2010
\n\n \n\n\n\n
12:00 AMAn amendment to the SC 13G filing - Form SC 13G/A\n\n \n\n
12:00 AMA statement of beneficial ownership of common stock by certain persons - Form SC 13G\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 08, 2010
\n\n \n\n\n\n
12:00 AMReport of unscheduled material events or corporate changes - Form 8-K\n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 18, 2009
\n\n \n\n\n\n
12:00 AMAmendment to a previously filed 4 - Form 4/A\n\n \n\n
\n\n More Filings for OSIP >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");